이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Lotus Eye Hospital and Institute 관리
관리 기준 확인 4/4
Lotus Eye Hospital and Institute's CEO는 Kuttapalayam Ramalingam, Aug2020 에 임명되었습니다 의 임기는 3.83 년입니다. 는 ₹ 18.72M 가치에 해당하는 회사 주식의 1.43% 직접 소유합니다. 18.72M. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 4.5 년입니다.
주요 정보
Kuttapalayam Ramalingam
최고 경영자
₹1.2m
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 3.9yrs |
| CEO 소유권 | 1.4% |
| 경영진 평균 재임 기간 | 3.8yrs |
| 이사회 평균 재임 기간 | 4.6yrs |
최근 관리 업데이트
Recent updates
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06CEO
Kuttapalayam Ramalingam (75 yo)
3.9yrs
테뉴어
₹1,200,000
보상
Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 3.9yrs | ₹1.20m | 1.43% ₹ 17.4m | |
| Chief Financial Officer | 2.2yrs | ₹1.55m | 데이터 없음 | |
| Company Secretary & Compliance Officer | 2.4yrs | ₹981.00k | 데이터 없음 | |
| MD & Director | 3.8yrs | ₹1.20m | 18.84% ₹ 229.0m | |
| Vice President of Administration | 6.2yrs | 데이터 없음 | 0.84% ₹ 10.2m |
3.8yrs
평균 재임 기간
67yo
평균 연령
경험이 풍부한 관리: LOTUSEYE 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Executive Director | 3.4yrs | ₹1.20m | 1.43% ₹ 17.4m | |
| MD & Director | 4.7yrs | ₹1.20m | 18.84% ₹ 229.0m | |
| Vice President of Administration | 4.5yrs | 데이터 없음 | 0.84% ₹ 10.2m | |
| Non-Executive Independent Director | 16.8yrs | ₹200.00k | 데이터 없음 | |
| Chairman of the Board | 8.2yrs | ₹200.00k | 18.78% ₹ 228.3m | |
| Non-Executive Independent Director | 16.8yrs | ₹200.00k | 데이터 없음 | |
| Non-Executive Independent Director | 12.2yrs | ₹200.00k | 데이터 없음 | |
| Independent Director | 3.5yrs | ₹200.00k | 데이터 없음 | |
| Independent Non-Executive Director | 1.6yrs | ₹50.00k | 데이터 없음 | |
| Independent Non-Executive Director | 1.4yrs | 데이터 없음 | 데이터 없음 |
4.6yrs
평균 재임 기간
75.5yo
평균 연령
경험이 풍부한 이사회: LOTUSEYE 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.